Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

February 2015; Volume 35,Issue 2

Reviews

  • You have access
    Curcumin and Cancer Stem Cells: Curcumin Has Asymmetrical Effects on Cancer and Normal Stem Cells
    PETER P. SORDILLO and LAWRENCE HELSON
    Anticancer Research February 2015, 35 (2) 599-614;
  • You have access
    Mechanisms and Clinical Significance of Histone Deacetylase Inhibitors: Epigenetic Glioblastoma Therapy
    PHILIP LEE, BEN MURPHY, RICKEY MILLER, VIVEK MENON, NAREN L. BANIK, PIERRE GIGLIO, SCOTT M. LINDHORST, ABHAY K. VARMA, WILLIAM A. VANDERGRIFT, SUNIL J. PATEL and ARABINDA DAS
    Anticancer Research February 2015, 35 (2) 615-625;
  • You have access
    Targeting the Peritoneum with Novel Drug Delivery Systems in Peritoneal Carcinomatosis: A Review of the Literature
    THIJS RALF VAN OUDHEUSDEN, HOLGER GRULL, PATRICIA YVONNE WILHELMINA DANKERS and IGNACE HUBERTUS JOHANNES THEODORUS DE HINGH
    Anticancer Research February 2015, 35 (2) 627-634;
  • You have access
    Mode of Action of Anticancer Peptides (ACPs) from Amphibian Origin
    CHRISTOPHER OELKRUG, MARTIN HARTKE and ANDREAS SCHUBERT
    Anticancer Research February 2015, 35 (2) 635-643;
  • You have access
    Potential Anticancer Properties and Mechanisms of Action of Curcumin
    NATALIA G. VALLIANOU, ANGELOS EVANGELOPOULOS, NIKOS SCHIZAS and CHRISTOS KAZAZIS
    Anticancer Research February 2015, 35 (2) 645-651;

Experimental Studies

  • You have access
    In Vitro Evaluation of 3-Arylcoumarin Derivatives in A549 Cell Line
    MUSILIYU A. MUSA, MOISE Y. JOSEPH, LEKAN M. LATINWO, VEERA BADISA and JOHN S. COOPERWOOD
    Anticancer Research February 2015, 35 (2) 653-659;
  • You have access
    Complementarity of Variable-magnification and Spectral-separation Fluorescence Imaging Systems for Noninvasive Detection of Metastasis and Intravital Detection of Single Cancer Cells in Mouse Models
    YONG ZHANG, YUKIHIKO HIROSHIMA, HUAIYU MA, NAN ZHANG, MING ZHAO and ROBERT M. HOFFMAN
    Anticancer Research February 2015, 35 (2) 661-667;
  • You have access
    GLI1, CTNNB1 and NOTCH1 Protein Expression in a Thymic Epithelial Malignancy Tissue Microarray
    JONATHAN W. RIESS, ROBERT WEST, MICHELLE DEAN, ALEX C. KLIMOWICZ, JOEL W. NEAL, CHUONG HOANG and HEATHER A. WAKELEE
    Anticancer Research February 2015, 35 (2) 669-676;
  • You have access
    Expression of xCT as a Predictor of Disease Recurrence in Patients with Colorectal Cancer
    KENJI SUGANO, KIYOSHI MAEDA, HIROSHI OHTANI, HISASHI NAGAHARA, MASATSUNE SHIBUTANI and KOSEI HIRAKAWA
    Anticancer Research February 2015, 35 (2) 677-682;
  • You have access
    Detection of Circulating Tumor Cells in High-risk Endometrial Cancer
    GIORGIO BOGANI, MINETTA C. LIU, SEAN C. DOWDY, WILLIAM A. CLIBY, SARAH E. KERR, KIMBERLY R. KALLI, BENJAMIN R. KIPP, KEVIN C. HALLING, MICHAEL B. CAMPION and ANDREA MARIANI
    Anticancer Research February 2015, 35 (2) 683-687;
  • You have access
    Involvement of mTOR Signaling Pathways in Regulating Growth and Dissemination of Metastatic Brain Tumors via EMT
    AMANDA KWASNICKI, DHRUVE JEEVAN, ALEX BRAUN, RAJ MURALI and MEENA JHANWAR-UNIYAL
    Anticancer Research February 2015, 35 (2) 689-696;
  • You have access
    Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely Mimics the Patient Behavior in Contrast to the Subcutaneous Ectopic Model
    YUKIHIKO HIROSHIMA, YONG ZHANG, NAN ZHANG, FUMINARI UEHARA, ALI MAAWY, TAKASHI MURAKAMI, SUMIYUKI MII, MAKO YAMAMOTO, SHINJI MIWA, SHUYA YANO, MASASHI MOMIYAMA, RYUTARO MORI, RYUSEI MATSUYAMA, TAKASHI CHISHIMA, KUNIYA TANAKA, YASUSHI ICHIKAWA, MICHAEL BOUVET, ITARU ENDO and ROBERT M. HOFFMAN
    Anticancer Research February 2015, 35 (2) 697-701;
  • You have access
    Tumor Progression Is Associated with Increasing CD11b+ Cells and CCL2 in Lewis Rat Sarcoma
    RAJBARDHAN MISHRA, JANA KOVALSKA, JOZEF JANDA, LUCA VANNUCCI, RADKO RAJMON and VRATISLAV HORAK
    Anticancer Research February 2015, 35 (2) 703-711;
  • You have access
    Treatment of Transmissible Venereal Tumors in Dogs with Intratumoral Interleukin-2 (IL-2). A Pilot Study
    WILLEM DEN OTTER, MARGOT HACK, JOHN J.L. JACOBS, JURGEN F.V. TAN, LAWRENCE ROZENDAAL and R. JEROEN A. VAN MOORSELAAR
    Anticancer Research February 2015, 35 (2) 713-717;
  • You have access
    MicroRNA Profiles to Predict Postoperative Prognosis in Patients with Small Cell Carcinoma of the Esophagus
    TOMOYUKI OKUMURA, YUTAKA SHIMADA, TETSUYA OMURA, KATSUHISA HIRANO, TAKUYA NAGATA and KAZUHIRO TSUKADA
    Anticancer Research February 2015, 35 (2) 719-727;
  • You have access
    Cantharidin Impairs Cell Migration and Invasion of A375.S2 Human Melanoma Cells by Suppressing MMP-2 and -9 Through PI3K/NF-κB Signaling Pathways
    BIN-CHUAN JI, YU-PING HSIAO, CHUNG HUNG TSAI, SHU-JEN CHANG, SHU-CHUN HSU, HSIN-CHUNG LIU, YI-PING HUANG, JIN-CHERNG LIEN and JING-GUNG CHUNG
    Anticancer Research February 2015, 35 (2) 729-738;
  • You have access
    Renal Fibrogenesis and Platinum Compounds in a Rat Model: A Novel Pt (II) Complex vs. Cisplatin
    CARLA FENOGLIO, FEDERICA ALBICINI, SANDRA ANGELICA DE PASCALI, GLORIA MILANESI, MARCO FUMAGALLI, DANILO MIGONI, FRANCESCO PAOLO FANIZZI and GRAZIELLA BERNOCCHI
    Anticancer Research February 2015, 35 (2) 739-751;
  • You have access
    Multi-Responsive Polymer Micelles as Ellipticine Delivery Carriers for Cancer Therapy
    MARTIN STUDENOVSKÝ, ONDŘEJ SEDLÁČEK, MARTIN HRUBÝ, JIŘÍ PÁNEK and KAREL ULBRICH
    Anticancer Research February 2015, 35 (2) 753-757;
  • You have access
    Differential Expression of E-Cadherin in Primary Breast Cancer and Corresponding Lymph Node Metastases
    VEACESLAV FULGA, LUCIAN RUDICO, AMALIA RALUCA BALICA, ANCA MARIA CIMPEAN, LILIAN SAPTEFRATI, MADALIN-MARIUS MARGAN and MARIUS RAICA
    Anticancer Research February 2015, 35 (2) 759-765;
  • You have access
    Resveratrol Induces Apoptosis and Alters Gene Expression in Human Fibrosarcoma Cells
    KAMRAN HARATI, PAWEL SLODNIK, ANSGAR MICHAEL CHROMIK, OLE GOERTZ, TOBIAS HIRSCH, NIKOLAI KAPALSCHINSKI, LUDGER KLEIN-HITPASS, JONAS KOLBENSCHLAG, WALDEMAR UHL, MARCUS LEHNHARDT and ADRIEN DAIGELER
    Anticancer Research February 2015, 35 (2) 767-774;
  • You have access
    Comparative Effects of 4-Phenyl-3-Butenoic Acid and Vorinostat on Cell Growth and Signaling
    TIMOTHY J. BURNS, AMNA ALI and DIANE F. MATESIC
    Anticancer Research February 2015, 35 (2) 775-784;
  • You have access
    Prolyl Isomerase PIN1 Negatively Regulates SGK1 Stability to Mediate Tamoxifen Resistance in Breast Cancer Cells
    ARA JO, HYO JEONG YUN, JIN YOUNG KIM, SUNG-CHUL LIM, HUI JEONG CHOI, BONG SEOK KANG, BU-YOUNG CHOI and HONG SEOK CHOI
    Anticancer Research February 2015, 35 (2) 785-794;
  • You have access
    Cantharidin Induces DNA Damage and Inhibits DNA Repair-associated Protein Expressions in TSGH8301 Human Bladder Cancer Cell
    JEHN-HWA KUO, TING-YING SHIH, JING-PIN LIN, KUANG-CHI LAI, MENG-LIANG LIN, MEI-DUE YANG and JING-GUNG CHUNG
    Anticancer Research February 2015, 35 (2) 795-804;
  • You have access
    Vitamin D Effect on Growth and Vitamin D Metabolizing Enzymes in Triple-negative Breast Cancer
    SARAH E. RICHARDS, KAYTIE A. WEIERSTAHL and JESSICA L. KELTS
    Anticancer Research February 2015, 35 (2) 805-810;
  • You have access
    Synthesis and Structure–Activity Relationship Studies of Furan-ring Fused Chalcones as Antiproliferative Agents
    YUSUKE SAITO, MAHO KISHIMOTO, YUKO YOSHIZAWA and SATORU KAWAII
    Anticancer Research February 2015, 35 (2) 811-817;
  • You have access
    The Role of KISS1/KISS1R System in Tumor Growth and Invasion of Differentiated Thyroid Cancer
    CHRISTOS SAVVIDIS, ELENI PAPAOICONOMOU, CONSTANTINA PETRAKI, PAVLOS MSAOUEL and MICHAEL KOUTSILIERIS
    Anticancer Research February 2015, 35 (2) 819-826;
  • You have access
    Langmuir-Blodgett (LB)-based Nanobiocrystallography at the Frontiers of Cancer Proteomics
    EUGENIA PECHKOVA, NICOLA LUIGI BRAGAZZI, STEFANO FIORDORO and CLAUDIO NICOLINI
    Anticancer Research February 2015, 35 (2) 827-834;
  • You have access
    In Vitro Efficacy of Cinnarizine Against Lymphoma and Multiple Myeloma
    LEONARD CHRISTOPHER SCHMEEL, FREDERIC CARSTEN SCHMEEL, YOUNG KIM, SABINE BLAUM-FEDER, TOMOYUKI ENDO and INGO G.H. SCHMIDT-WOLF
    Anticancer Research February 2015, 35 (2) 835-841;
  • You have access
    Attenuated Salmonella enterica Typhimurium Reduces Tumor Burden in an Autochthonous Breast Cancer Model
    JEREMY DREES, MICHAEL MERTENSOTTO, GARVEY LIU, JAYANTH PANYAM, ARNOLD LEONARD, LANCE AUGUSTIN, JANET SCHOTTEL and DANIEL SALTZMAN
    Anticancer Research February 2015, 35 (2) 843-849;
  • You have access
    Human Papillomavirus and Breast Cancer: No Evidence of Association in a Spanish Set of Cases
    MARIA VERNET-TOMAS, MARISA MENA, LAIA ALEMANY, IGNACIO BRAVO, SILVIA DE SANJOSÉ, PAU NICOLAU, ALBA BERGUEIRO, JOSEP MARIA COROMINAS, SERGI SERRANO, RAMON CARRERAS and BELEN LLOVERAS
    Anticancer Research February 2015, 35 (2) 851-856;
  • You have access
    Which Sequence Best Protects the Heart Against Trastuzumab and Anthracycline Toxicity? An Electron Microscopy Study in Rats
    NEYRAN KERTMEN, SERCAN AKSOY, AYSEGUL UNER, MUSTAFA SARGON, OZGUR OZKAYAR, OZGE KESKIN, TANER BABACAN, FURKAN SARICI, MEHMET AN SENDUR, ZAFER ARIK, SERKAN AKIN and KADRI ALTUNDAG
    Anticancer Research February 2015, 35 (2) 857-864;

Clinical Studies

  • You have access
    Macrophage-Colony Stimulating Factor (CSF1) Predicts Breast Cancer Progression and Mortality
    ELIN RICHARDSEN, REBECCA DALE UGLEHUS, STEIN HARALD JOHNSEN and LILL-TOVE BUSUND
    Anticancer Research February 2015, 35 (2) 865-874;
  • You have access
    Rare Case of a Primary Intracranial Chondrosarcoma
    ELISABETH SMOLLE, MICHAEL MOKRY and JOHANNES HAYBAECK
    Anticancer Research February 2015, 35 (2) 875-880;
  • You have access
    Proteomic Identification of Autoantibodies in Sera from Patients with Ovarian Cancer as Possible Diagnostic Biomarkers
    KOICHI YONEYAMA, SHIGEYUKI KOJIMA, YOSHIKO KODANI, NOZOMI YAMAGUCHI, AKIRA IGARASHI, KEISUKE KUROSE, RIEKO KAWASE, TOSHIYUKI TAKESHITA, SEISUKE HATTORI and KINYA NAGATA
    Anticancer Research February 2015, 35 (2) 881-889;
  • You have access
    Chylothorax After Esophagectomy Cured by Intranodal Lymphangiography: A Case Report
    MASAAKI YAMAMOTO, HIROSHI MIYATA, MAKOTO YAMASAKI, NOBORU MAEDA, YASUHIRO MIYAZAKI, TSUYOSHI TAKAHASHI, YUKINORI KUROKAWA, KIYOKAZU NAKAJIMA, SHUJI TAKIGUCHI, MASAKI MORI and YUICHIRO DOKI
    Anticancer Research February 2015, 35 (2) 891-895;
  • You have access
    Survival Outcome of Borrmann Type IV Gastric Cancer Potentially Improved by Multimodality Treatment
    KEISHI YAMASHITA, KEI HOSODA, NATSUYA KATADA, HIROMITSU MORIYA, HIROAKI MIENO, KATSUHIKO HIGUCHI, TOHRU SASAKI, CHIKATOSHI KATADA, SHINICHI SAKURAMOTO, SATOSHI TANABE, WASABURO KOIZUMI, SHIRO KIKUCHI and MASAHIKO WATANABE
    Anticancer Research February 2015, 35 (2) 897-906;
  • You have access
    Neoadjuvant Docetaxel/Cyclophosphamide in Triple-negative Breast Cancer: Predictive Value of Class III-β Tubulin and Non-basal Subtype
    KAZUHIRO SHIMADA, TAKASHI ISHIKAWA, KUMIKO KITA, KAZUTAKA NARUI, SADAYOSHI SUGAE, DAISUKE SHIMIZU, MIKIKO TANABE, TAKESHI SASAKI, TAKASHI CHISHIMA, YASUSHI ICHIKAWA and ITARU ENDO
    Anticancer Research February 2015, 35 (2) 907-912;
  • You have access
    Age Influences the Clinical Significance of Atypical Glandular Cells on Cytology
    KATRIN CHRISTINE ASCIUTTO, EMIR HENIC, OLA FORSLUND, KAJ BJELKENKRANTZ and CHRISTER BORGFELDT
    Anticancer Research February 2015, 35 (2) 913-919;
  • You have access
    VEGFR3 and CD31 as Prognostic Factors in Renal Cell Cancer
    JUHA VIRMAN, PETRI BONO, TIINA LUUKKAALA, KAISA SUNELA, PAULA KUJALA and PIRKKO-LIISA KELLOKUMPU-LEHTINEN
    Anticancer Research February 2015, 35 (2) 921-927;
  • You have access
    β-Catenin Helices in the Cytoplasm of Sessile Serrated Adenoma/Polyps and Conventional Colorectal Adenomas
    CARLOS A. RUBIO, ANN KAUFELDT, RAFAT KOHA, MARIKO USHOIDA, JENNY LINDAHL and LORAND L. KIS
    Anticancer Research February 2015, 35 (2) 929-934;
  • You have access
    Radiobiological Treatment Planning Evaluation of Inverse Planning Simulated Annealing for Cervical Cancer High-dose-rate Brachytherapy
    TOMAS PALMQVIST, LUCÍLIO DOS S.MATIAS, ANNE B.L. MARTHINSEN, MARIT SUNDSET, ANNE D. WANDERÅS, SIGNE DANIELSEN and IULIANA TOMA-DASU
    Anticancer Research February 2015, 35 (2) 935-939;
  • You have access
    The Relation of Hopelessness/Helplessness versus Beck Depression Inventory (BDI) in Healthy Individuals and in Patients with Benign Breast Disease and Breast Cancer: A Prospective Case-control Study in Finland
    MATTI ESKELINEN, RIIKA KORHONEN, TUOMAS SELANDER and PAULA OLLONEN
    Anticancer Research February 2015, 35 (2) 941-947;
  • You have access
    Low PHLDA3 Expression in Oesophageal Squamous Cell Carcinomas Is Associated with Poor Prognosis
    HIROTO MUROI, MASANOBU NAKAJIMA, HITOSHI SATOMURA, MASAKAZU TAKAHASHI, SATORU YAMAGUCHI, KINRO SASAKI, TAKEHIKO YOKOBORI, TATSUYA MIYAZAKI, HIROYUKI KUWANO and HIROYUKI KATO
    Anticancer Research February 2015, 35 (2) 949-954;
  • You have access
    Assessment of Grading in Newly-diagnosed Glioma Using 18F-Fluorothymidine PET/CT
    EVA FERDOVÁ, JIŘÍ FERDA, JAN BAXA, RADEK TUPÝ, JAN MRAČEK, ONDŘEJ TOPOLČAN and ONDREJ HES
    Anticancer Research February 2015, 35 (2) 955-959;
  • You have access
    Inter- and Intra-observer Variability in Biopsy of Bone and Soft Tissue Sarcomas
    HEINRICH M.L. MÜHLHOFER, ULRICH LENZE, FLORIAN LENZE, INA-CHRISTINE RONDAK, JOHANNES SCHAUWECKER, HANS RECHL, RUEDIGER VON EISENHART-ROTHE and FLORIAN POHLIG
    Anticancer Research February 2015, 35 (2) 961-966;
  • You have access
    FDG PET/CT and MR Imaging of CD34-Negative Soft-tissue Solitary Fibrous Tumor with NAB2-STAT6 Fusion Gene
    JUN NISHIO, HIROSHI IWASAKI, MIKIKO AOKI, KAZUKI NABESHIMA and MASATOSHI NAITO
    Anticancer Research February 2015, 35 (2) 967-971;
  • You have access
    Claudin-5 Is Associated with Elevated TATI and CA125 Levels in Mucinous Ovarian Borderline Tumors
    RITVA NISSI, ANNE TALVENSAARI-MATTILA, PAULA KUVAJA, PAAVO PÄÄKKÖ, YLERMI SOINI and MARKKU SANTALA
    Anticancer Research February 2015, 35 (2) 973-976;
  • You have access
    Feasibility Study of Alternate-day S-1 as Adjuvant Chemotherapy for Head and Neck Cancer
    YORIHISA MORO, YASUNAO KOGASHIWA, DAI SATO, YOSHIFUMI MATSUMOTO, TAKEHIRO NAKAMURA, KOICHI YAMAUCHI, HIROYUKI SAKURAI and NAOYUKI KOHNO
    Anticancer Research February 2015, 35 (2) 977-981;
  • You have access
    Prognostic Factors in Cancer Patients with Symptomatic Pituitary Metastasis: A Clinical Case Study
    CHUN-YU LIN, WEN-KUAN HUANG, FU-TSAI CHUNG and HSIEN-KUN CHANG
    Anticancer Research February 2015, 35 (2) 983-987;
  • You have access
    Left Ventricular Systolic Dysfunction in Metastatic Breast Cancer Patients: A Polish Multicenter Registry
    SEBASTIAN SZMIT, JOANNA STREB, WIOLETTA STARZEC, DOROTA ZUZIAK, MARIUSZ KWIATKOWSKI, BOGUMIŁA CZARTORYSKA-ARŁUKOWICZ, DARIUSZ IŻYCKI, ANNA ŚMIAŁOWSKA-JANISZEWSKA, JERZY HANSLIK, AGNIESZKA BRYJAK, MAŁGORZATA TALERCZYK and JAN MACIEJ ZAUCHA
    Anticancer Research February 2015, 35 (2) 989-995;
  • You have access
    Preoperative Serum Methylation Signature as Prognostic Tool After Curative Hepatectomy in Patients with Hepatocellular Carcinoma
    SHINSUKE KANEKIYO, NORIO IIZUKA, RYOICHI TSUNEDOMI, YUKIO TOKUMITSU, NORIAKI HASHIMOTO, YOSHIHIRO TOKUHISA, YOSHINARI MAEDA, MICHIHISA IIDA, KAZUHIKO SAKAMOTO, TAKAO TAMESA, YUSUKE FUJITA, SHIGEFUMI YOSHINO, SHOICHI HAZAMA, YOSHIHIKO HAMAMOTO and MASAAKI OKA
    Anticancer Research February 2015, 35 (2) 997-1007;
  • You have access
    Correlation Between 18F-FDG-uptake and In Vitro Chemosensitivity of Cisplatin in Head and Neck Cancer
    HIDENORI SUZUKI, MASAMI NISHIO, NOBUHIRO HANAI, HITOSHI HIRAKAWA, TSUNEO TAMAKI and YASUHISA HASEGAWA
    Anticancer Research February 2015, 35 (2) 1009-1016;
  • You have access
    Improving the Prediction of Pathologic Outcomes in Patients Undergoing Radical Prostatectomy: The Value of Prostate Cancer Antigen 3 (PCA3), Prostate Health Index (Phi) and Sarcosine
    MATTEO FERRO, GIUSEPPE LUCARELLI, DARIO BRUZZESE, SISTO PERDONÀ, CLAUDIA MAZZARELLA, GIUSEPPE PERRUOLO, ADA MARINO, VINCENZO COSIMATO, EMILIA GIORGIO, VIRGINIA TAGLIAMONTE, DANILO BOTTERO, OTTAVIO DE COBELLI and DANIELA TERRACCIANO
    Anticancer Research February 2015, 35 (2) 1017-1023;
  • You have access
    Prognostic Impact of Central Nervous System Metastases After Acquired Resistance to EGFR-TKI: Poorer Prognosis Associated with T790M-negative Status and Leptomeningeal Metastases
    AKITO HATA, NOBUYUKI KATAKAMI, HIROSHIGE YOSHIOKA, JUMPEI TAKESHITA, KOSUKE TANAKA, KATSUHIRO MASAGO, SHIRO FUJITA, REIKO KAJI, YUKIHIRO IMAI, KAZUYA MONDEN, TAKESHI MATSUMOTO, KAZUMA NAGATA, KYOKO OTSUKA, RYO TACHIKAWA, KEISUKE TOMII, KEI KUNIMASA, MASAHIRO IWASAKU, AKIHIRO NISHIYAMA, TADASHI ISHIDA and YOSHIHIRO NISHIMURA
    Anticancer Research February 2015, 35 (2) 1025-1031;
  • You have access
    Surgical Option for Intestinal Gastrointestinal Stromal Tumors – Perioperative and Oncological Outcomes of Laparoscopic Surgery
    CHIEN-HUNG LIAO, CHUN-NAN YEH, SHANG-YU WANG, CHIH-YUAN FU, CHUN-YI TSAI, YU-YIN LIU, CHI-TUNG CHENG and TA-SEN YEH
    Anticancer Research February 2015, 35 (2) 1033-1040;
  • You have access
    Lymphatic and Blood Vessels in Male Breast Cancer
    JOANNA NIEMIEC, BEATA SAS-KORCZYNSKA, AGNIESZKA HARAZIN-LECHOWSKA, DARIUSZ MARTYNOW and AGNIESZKA ADAMCZYK
    Anticancer Research February 2015, 35 (2) 1041-1048;
  • You have access
    Immunohistochemical Expression of Sex Steroid Hormone Receptors, Cell Cycle Regulators and Angiogenesis Factors in Intraductal Papillary Mucinous Neoplasms: An Explorative Study
    DESPOINA GEORGIADOU, THEODOROS N. SERGENTANIS, STRATIGOULA SAKELLARIOU, GEORGE M. FILIPPAKIS, FLORA ZAGOURI, THEODORA PSALTOPOULOU, ANDREAS C. LAZARIS, EFSTRATIOS PATSOURIS, ANTONIA GOUNARIS and GEORGE C. ZOGRAFOS
    Anticancer Research February 2015, 35 (2) 1049-1056;
  • You have access
    Predictive Factors for Response to Abiraterone in Metastatic Castration Refractory Prostate Cancer
    MEHRAN AFSHAR, FAWAZ AL-ALLOOSH, SARAH PIRRIE, CLARE ROWAN, NICHOLAS D. JAMES and EMILIO PORFIRI
    Anticancer Research February 2015, 35 (2) 1057-1063;
  • You have access
    Difference in Benefit of Chemotherapy Between Small Cell Lung Cancer Patients with Interstitial Pneumonia and Patients with Non-small Cell Lung Cancer
    KOSUKE KASHIWABARA, HIROSHI SEMBA, SHINJI FUJII, SHINSUKE TSUMURA and RYOTA AOKI
    Anticancer Research February 2015, 35 (2) 1065-1071;
  • You have access
    Clinicopathological Characteristics of Multiple Primary Cancers in Hepatobiliary and Pancreas Malignancies
    ATSUSHI NANASHIMA, HISAYOSHI KONDO, MASAHIRO NAKASHIMA, TAKAFUMI ABO, JUNICHI ARAI, MITSUTOSHI ISHII, SHIGEKAZU HIDAKA, MASAKI KUNIZAKI, KAZUO TO, HIROAKI TAKESHITA, NAOYA YAMASAKI, TOMOSHI TSUCHIYA and TAKESHI NAGAYASU
    Anticancer Research February 2015, 35 (2) 1073-1083;
  • You have access
    Angiogenic Markers in Plasma Cell Myeloma Patients Treated with Novel Agents
    MICHAEL MEDINGER, JÖRG HALTER, DOMINIK HEIM, ANDREAS BUSER, SABINE GERULL, MARTIN STERN and JAKOB PASSWEG
    Anticancer Research February 2015, 35 (2) 1085-1090;
  • You have access
    Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma
    ÉVA STÁNITZ, KRISZTINA JUHÁSZ, KATALIN GOMBOS, KATALIN GŐCZE, CSABA TÓTH and ISTVÁN KISS
    Anticancer Research February 2015, 35 (2) 1091-1097;
  • You have access
    Correlation Between CA125 Levels After Sixth Cycle of Chemotherapy and Clinical Outcome in Advanced Ovarian Carcinoma
    ANGIOLO GADDUCCI, ALICE MENICHETTI, ILARIA GUIGGI, MARGHERITA NOTARNICOLA and STEFANIA COSIO
    Anticancer Research February 2015, 35 (2) 1099-1104;
  • You have access
    Predictive Biomarkers to Chemotherapy in Patients with Advanced Melanoma Receiving the Combination of Cisplatin - Vinblastine - Temozolomide (PVT) as First-line Treatment: A Study of the Hellenic Cooperative Oncology Group (HECOG)
    HELENA LINARDOU, GEORGE PENTHEROUDAKIS, IOANNIS VARTHALITIS, HELEN GOGAS, DIMITRIOS PECTASIDES, THOMAS MAKATSORIS, GEORGE FOUNTZILAS, DIMITRIOS BAFALOUKOS and The Hellenic Cooperative Oncology Group
    Anticancer Research February 2015, 35 (2) 1105-1113;
  • You have access
    Cyclin I mRNA Expression Correlates with Kinase Insert Domain Receptor Expression in Human Epithelial Ovarian Cancer
    MAREK CYBULSKI, WITOLD JELENIEWICZ, ANDRZEJ NOWAKOWSKI, AGNIESZKA STENZEL-BEMBENEK, RAFAŁ TARKOWSKI, JAN KOTARSKI and ANDRZEJ STEPULAK
    Anticancer Research February 2015, 35 (2) 1115-1119;
  • You have access
    Second Primary Lung Cancers Among Breast Cancer Patients Treated with Anti-estrogens Have a Longer Cancer-specific Survival
    LI-HAN HSU, AN-CHEN FENG, SHU-HUEI KAO, CHIA-CHUAN LIU, STELLA Y.C. TSAI, LI-SUN SHIH and NEI-MIN CHU
    Anticancer Research February 2015, 35 (2) 1121-1127;
  • You have access
    Levels of Vascular Endothelial Growth Factor in Serum and Pleural Fluid Are Independent Predictors of Survival in Advanced Non-small Cell Lung Cancer: Results of a Prospective Study
    IOANNIS GKIOZOS, SOFIA TSAGOULI, ANDRIANI CHARPIDOU, DIMITRA GRAPSA, ELIAS KAINIS, CHRISTINA GRATZIOU and KONSTANTINOS SYRIGOS
    Anticancer Research February 2015, 35 (2) 1129-1137;
  • You have access
    Abstracts of the Christie International Student Cancer Conference
    Anticancer Research February 2015, 35 (2) 1139-1141;
  • PROCEEDINGS OF THE 5TH INTERNATIONAL SYMPOSIUM ON VITAMIN D AND ANALOGS IN CANCER PREVENTION AND THERAPY, 2-3 May, 2014, Krefeld, Germany

    • You have access
      What Do We Learn from the Genome-wide Perspective on Vitamin D3?
      CARSTEN CARLBERG
      Anticancer Research February 2015, 35 (2) 1143-1151;
    • You have access
      25-Hydroxyvitamin D and Breast Cancer, Colorectal Cancer, and Colorectal Adenomas: Case–Control versus Nested Case–Control Studies
      WILLIAM B. GRANT
      Anticancer Research February 2015, 35 (2) 1153-1160;
    • You have access
      Vitamin D in Preventive Medicine
      STEFAN PILZ, MARTIN GAKSCH, BRÍAIN Ó HARTAIGH, ANDREAS TOMASCHITZ and WINFRIED MÄRZ
      Anticancer Research February 2015, 35 (2) 1161-1170;
    • You have access
      Vitamin D Levels and Dietary Intake Among Patients with Benign Soft Tissue Tumors and Sarcomas
      ASTA JUZENIENE, ALINA CARMEN POROJNICU, ZIVILE BATURAITE, ZOYA LAGUNOVA, LAGE AKSNES, ØYVIND SVERRE BRULAND and JOHAN MOAN
      Anticancer Research February 2015, 35 (2) 1171-1180;
    • You have access
      Vitamin D Status and Cancer Prevalence of Hemodialysis Patients in Germany
      PHILIPP MARQUARDT, ROLFDIETER KRAUSE, MATHIAS SCHALLER, DIETER BACH and GERO VON GERSDORFF
      Anticancer Research February 2015, 35 (2) 1181-1187;
    • You have access
      Combined Treatment of Breast Cancer Cell Lines with Vitamin D and COX-2 Inhibitors
      MARC THILL, KATHRIN REICHERT, ALENA WOESTE, STEPHAN POLACK, DOROTHEA FISCHER, FRIEDERIKE HOELLEN, ACHIM RODY, MICHAEL FRIEDRICH and FRANK KÖSTER
      Anticancer Research February 2015, 35 (2) 1189-1195;
    • You have access
      Vitamin D Inhibits Ovarian Cancer Cell Line Proliferation in Combination with Celecoxib and Suppresses Cyclooxygenase-2 Expression
      MARC THILL, ALENA WOESTE, KATHRIN REICHERT, DOROTHEA FISCHER, ACHIM RODY, MICHAEL FRIEDRICH and FRANK KÖSTER
      Anticancer Research February 2015, 35 (2) 1197-1203;
    • You have access
      Development of Efficient Chemical Syntheses of Vitamin D Degradation Products
      LARS KATTNER, DAN BERNARDI and ERIK RAUCH
      Anticancer Research February 2015, 35 (2) 1205-1210;
    • You have access
      Effect of Serum Cotinine on Vitamin D Serum Concentrations Among American Females with Different Ethnic Backgrounds
      KIANO REZA MANAVI, BRENDA P. ALSTON-MILLS, MARVIN P. THOMPSON and JONATHAN C. ALLEN
      Anticancer Research February 2015, 35 (2) 1211-1218;

Errata

  • You have access
    Errata
    Anticancer Research February 2015, 35 (2) 1219;
  • You have access
    Errata
    Anticancer Research February 2015, 35 (2) 1219;
  • You have access
    Errata
    Anticancer Research February 2015, 35 (2) 1219;

BOOK REVIEWS

  • You have access
    Book Reviews
    Anticancer Research February 2015, 35 (2) 1221;
  • You have access
    The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents
    Anticancer Research February 2015, 35 (2) 1221;
  • You have access
    Functional Imaging in Oncology
    Anticancer Research February 2015, 35 (2) 1221;
  • You have access
    The Autoimmune Diseases. Fifth Edition
    Anticancer Research February 2015, 35 (2) 1221;
  • You have access
    Bone Cancer. Progression and Therapeutic Approaches
    Anticancer Research February 2015, 35 (2) 1221-1222;
  • You have access
    Clinical Genomics. A Guide to Clinical Next Generation Sequencing
    Anticancer Research February 2015, 35 (2) 1222;
  • You have access
    Autoantibodies
    Anticancer Research February 2015, 35 (2) 1222;
  • You have access
    Autophagy. Cancer, Other Pathologies, Inflammation, Immunity, Infection and Aging
    Anticancer Research February 2015, 35 (2) 1222;
  • You have access
    Animal Models for the Study of Human Disease
    Anticancer Research February 2015, 35 (2) 1222;
  • You have access
    Pharmacogenomics. Challenges and Opportunities in Therapeutic Implementation
    Anticancer Research February 2015, 35 (2) 1222;
  • You have access
    Decision Tools for Radiation Oncology. Prognosis, Treatment Response and Toxicity
    Anticancer Research February 2015, 35 (2) 1223;
  • You have access
    Billary Tract and Gallbladder Cancer. A Multidisciplinary Approach. Second Edition
    Anticancer Research February 2015, 35 (2) 1223;
  • You have access
    Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. A Practical Approach
    Anticancer Research February 2015, 35 (2) 1223;
  • You have access
    Photodynamic Therapy. From Theory to Application
    Anticancer Research February 2015, 35 (2) 1223;
  • You have access
    Angiogenesis and Anti-Angiogenesis in Hematological Malignancies
    Anticancer Research February 2015, 35 (2) 1223-1224;
  • You have access
    Phospholipases in Health and Disease
    Anticancer Research February 2015, 35 (2) 1224;
  • You have access
    Pathology of Melanocytic Nevi and Melanoma. Third Edition
    Anticancer Research February 2015, 35 (2) 1224;
  • You have access
    Monoclonal Antibodies. Methods and Protocols. Second Edition
    Anticancer Research February 2015, 35 (2) 1224;
  • You have access
    Innate DNA and RNA Recognition. Methods and Protocols
    Anticancer Research February 2015, 35 (2) 1224-1225;
  • You have access
    Transcription Factor Regulatory Networks. Methods and Protocols
    Anticancer Research February 2015, 35 (2) 1225;
  • You have access
    Exocytosis and Endocytosis. Second Edition
    Anticancer Research February 2015, 35 (2) 1225;
  • You have access
    DNA Vaccines. Methods and Protocols. Third Edition
    Anticancer Research February 2015, 35 (2) 1225;
  • You have access
    Autophagy in Health and Disease
    Anticancer Research February 2015, 35 (2) 1225;
  • You have access
    Stem cells. Scientific Facts and Fiction. Second Edition
    Anticancer Research February 2015, 35 (2) 1225-1226;
  • You have access
    Correlative Light and Electron Microscopy II
    Anticancer Research February 2015, 35 (2) 1226;
  • You have access
    Human Papillomavirus. Bench to Bedside
    Anticancer Research February 2015, 35 (2) 1226;
  • You have access
    Emerging Applications of Molecular Imaging to Oncology
    Anticancer Research February 2015, 35 (2) 1226;
  • You have access
    Cytokine Bioassays. Methods and Protocols
    Anticancer Research February 2015, 35 (2) 1226-1227;
  • You have access
    Hormones. Third Edition
    Anticancer Research February 2015, 35 (2) 1227;
  • You have access
    A Quick Guide to Cancer Epidemiology
    Anticancer Research February 2015, 35 (2) 1227;

Announcements

  • You have access
    Announcements
    Anticancer Research February 2015, 35 (2) 1228;
Back to top
PreviousNext

In this issue

Anticancer Research: 35 (2)
Anticancer Research
Vol. 35, Issue 2
February 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
    • PROCEEDINGS OF THE 5TH INTERNATIONAL SYMPOSIUM ON VITAMIN D AND ANALOGS IN CANCER PREVENTION AND THERAPY, 2-3 May, 2014, Krefeld, Germany
  • Errata
  • BOOK REVIEWS
  • Announcements
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire